Citi lowered the firm’s price target on Icon (ICLR) to $290 from $300 and keeps a Buy rating on the shares. Outside of the preannouncements and guidance updates from life science tools and diagnostics...
Source LinkCiti lowered the firm’s price target on Icon (ICLR) to $290 from $300 and keeps a Buy rating on the shares. Outside of the preannouncements and guidance updates from life science tools and diagnostics...
Source Link
Comments